Intensive Care Management of Patient after Cytoreductive Surgery and HIPEC: Where do we stand?

---

Review Article

Author Details : Surinder Singh Sodhi*

Volume : 1, Issue : 3, Year : 2023

Article Page : 93-98

Suggest article by email

---

Abstract

Cytoreductive surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) results in a number of physiological changes with effects on the cardiovascular system, oxygen consumption and coagulation. The Critical Care interventions required for this cohort of patients have not yet been quantified. The chemotherapy is administered in high dosages to the targeted area and washed out, thereby limiting the systemic toxicity. The procedure usually takes 8 to 18 hours and is most commonly used to treat appendiceal, colorectal or mesothelioma tumours including those that have failed standard chemotherapy and/or prior surgeries. Patients face major and life threatening derangements of their hemodynamic, respiratory and metabolic physiologic balance during the surgery and in the immediate postoperative period. Intensive monitoring and timely detection of possible complications and appropriate remedial action is crucial for better surgical results.

How to cite : Sodhi S S , Intensive Care Management of Patient after Cytoreductive Surgery and HIPEC: Where do we stand?. Onco Crit Care 2023;1(3):93-98

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.